Drug Shortage Report for DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP THERAPEUTIC
Report ID | 88353 |
Drug Identification Number | 02329778 |
Brand name | DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP THERAPEUTIC |
Common or Proper name | Sodium Iodide 131 |
Company Name | JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM IODIDE 131 I |
Strength(s) | 7400MBq |
Dosage form(s) | SOLUTION |
Route of administration | ORAL |
Packaging size | 1 Vial |
ATC code | V10XA |
ATC description | |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2019-07-06 |
Actual start date | |
Estimated end date | 2019-07-11 |
Actual end date | 2019-07-11 |
Shortage status | Resolved |
Updated date | 2019-07-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16751 TRANS CANADA HWY KIRKLAND, QUEBEC CANADA H9H 4J4 |
Company contact information | Hiba Soulaihi HSoulaihi@jubl.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-07-03 | English | Compare |
v2 | 2019-07-03 | French | Compare |
v3 | 2019-07-07 | English | Compare |
v4 | 2019-07-11 | English | Compare |
v5 | 2019-07-11 | French | Compare |
v6 | 2019-07-12 | English | Compare |
Showing 1 to 6 of 6